Literature DB >> 15516474

Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients.

I Fajac1, D Hubert, D Guillemot, I Honoré, T Bienvenu, F Volter, J Dall'Ava-Santucci, D J Dusser.   

Abstract

BACKGROUND: This study was conducted to determine whether the major nasal airway ion transport abnormalities in cystic fibrosis (that is, defective cAMP regulated chloride secretion and basal sodium hyperabsorption) are related to the clinical expression of cystic fibrosis and/or to the genotype.
METHODS: Nasal potential difference was measured in 79 adult patients with cystic fibrosis for whom clinical status, respiratory function, and CFTR genotype were determined.
RESULTS: In univariate and multivariate analysis, patients with pancreatic insufficiency were more likely to have low responses to low chloride (odds ratio (OR) 8.6 (95% CI 1.3 to 58.5), p = 0.03) and isoproterenol (OR 11.2 (95% CI 1.3 to 93.9), p = 0.03) solutions. Similarly, in univariate and multivariate analysis, patients with poor respiratory function (forced expiratory volume in 1 second <50% of predicted value) were more likely to have an enhanced response to amiloride solution (OR 3.7 (95% CI 1.3 to 11.0), p = 0.02). However, there was no significant relationship between nasal potential difference and the severity of the genotype.
CONCLUSIONS: Nasal epithelial ion transport in cystic fibrosis is linked to the clinical expression of the disease. The pancreatic status appears to be mostly related to the defect in epithelial chloride secretion whereas the respiratory status is mostly related to abnormal sodium transport and the regulatory function of the CFTR protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516474      PMCID: PMC1746881          DOI: 10.1136/thx.2003.020933

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  28 in total

1.  Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis.

Authors:  L P Ho; J M Samways; D J Porteous; J R Dorin; A Carothers; A P Greening; J A Innes
Journal:  Eur Respir J       Date:  1997-09       Impact factor: 16.671

Review 2.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.

Authors:  M J Welsh; A E Smith
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

Review 3.  Human airway ion transport. Part one.

Authors:  R C Boucher
Journal:  Am J Respir Crit Care Med       Date:  1994-07       Impact factor: 21.405

4.  Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.

Authors:  P G Middleton; D M Geddes; E W Alton
Journal:  Eur Respir J       Date:  1994-11       Impact factor: 16.671

5.  CFTR as a cAMP-dependent regulator of sodium channels.

Authors:  M J Stutts; C M Canessa; J C Olsen; M Hamrick; J A Cohn; B C Rossier; R C Boucher
Journal:  Science       Date:  1995-08-11       Impact factor: 47.728

6.  In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.

Authors:  M R Knowles; A M Paradiso; R C Boucher
Journal:  Hum Gene Ther       Date:  1995-04       Impact factor: 5.695

Review 7.  Cystic fibrosis: genotypic and phenotypic variations.

Authors:  J Zielenski; L C Tsui
Journal:  Annu Rev Genet       Date:  1995       Impact factor: 16.830

8.  Defective regulation of outwardly rectifying Cl- channels by protein kinase A corrected by insertion of CFTR.

Authors:  M Egan; T Flotte; S Afione; R Solow; P L Zeitlin; B J Carter; W B Guggino
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

9.  Prediction of mortality in patients with cystic fibrosis.

Authors:  E Kerem; J Reisman; M Corey; G J Canny; H Levison
Journal:  N Engl J Med       Date:  1992-04-30       Impact factor: 91.245

10.  Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents.

Authors:  E M Schwiebert; T Flotte; G R Cutting; W B Guggino
Journal:  Am J Physiol       Date:  1994-05
View more
  4 in total

1.  Chloride Conductance, Nasal Potential Difference and Cystic Fibrosis Pathophysiology.

Authors:  Elenara da Fonseca Andrade Procianoy; Fernando Antônio de Abreu E Silva; Paulo José Cauduro Maróstica; Paul M Quinton
Journal:  Lung       Date:  2019-11-16       Impact factor: 2.584

2.  Nasal potential difference measurements to assess CFTR ion channel activity.

Authors:  Steven M Rowe; John Paul Clancy; Michael Wilschanski
Journal:  Methods Mol Biol       Date:  2011

Review 3.  Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials.

Authors:  Steven M Rowe; Frank Accurso; John P Clancy
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

4.  Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?

Authors:  Katharina Niedermayr; Verena Gasser; Claudia Rueckes-Nilges; Dorothea Appelt; Johannes Eder; Teresa Fuchs; Lutz Naehrlich; Helmut Ellemunter
Journal:  Ther Adv Chronic Dis       Date:  2022-08-05       Impact factor: 4.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.